ZEAL:CPH
Zealand Pharma A/S
DKK २२९.१०
arrow_downward
-०.९५%(-२.२०) 1D
अक्टोबर १४, १४:०६:०५ GMT+२ · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
DKK २३२.००
High
DKK २३४.६०
Low
DKK २२७.४०
Mkt. cap
१६.८१ अरब
Avg. vol.
४.०३ लाख
Volume
१.६३ लाख
52-wk high
DKK ५५६.००
52-wk low
DKK २२७.४०
Shares outstanding
७.१६ करोड
No. of employees
५७८
Open
DKK २३२.००
High
DKK २३४.६०
Low
DKK २२७.४०
Mkt. cap
१६.८१ अरब
Avg. vol.
४.०३ लाख
Volume
१.६३ लाख
52-wk high
DKK ५५६.००
52-wk low
DKK २२७.४०
Shares outstanding
७.१६ करोड
No. of employees
५७८
News stories
From web sources and news partners
Euronext Markets: Real-time Stock Market Data | live
·
१५ घण्टा पहिले
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion
Investing.com Canada
·
१५ घण्टा पहिले
Zealand Pharma partners with Generate on AI drug development By Investing.com
Investing.com Canada
·
१५ घण्टा पहिले
Generate Biomedicines, Zealand Pharma form AI drug partnership By Investing.com
Stock Titan
·
१५ घण्टा पहिले
Up to nearly $1.2B in milestones is tied to Generate's planned AI research on obesity drugs.
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S